France· FR:67904304
MICROLAX SORBITOL CITRATE ET LAURILSULFOACETATE DE SODIUM, solution rectale en récipient unidose
A medicinal product containing citrate de sodium + sodium (laurilsulfoacétate de) + sorbitol à 70 pour cent cristallisable, registered in France by KENVUE FRANCE.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CITRATE DE SODIUM + SODIUM (LAURILSULFOACÉTATE DE) + SORBITOL À 70 POUR CENT CRISTALLISABLE
- Manufacturer
- KENVUE FRANCE
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 3
- cip1334009349687544 récipient(s) unidose(s) polyéthylène de 6,45 g avec canule polyéthylène
- cip13340093496881512 récipient(s) unidose(s) polyéthylène de 6,45 g avec canule polyéthylène
- cip13340095620724450 récipient(s) unidose(s) polyéthylène de 6,45 g avec canule polyéthylène
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7595e32c-88f0-4a1a-894c-edd1492724ef GET /v1/drugs/7595e32c-88f0-4a1a-894c-edd1492724ef?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "67904304",
"date_amm": "1995-06-29",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "CITRATE DE SODIUM + SODIUM (LAURILSULFOACÉTATE DE) + SORBITOL À 70 POUR CENT CRISTALLISABLE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution",
"voies_administration": "rectale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about citrate de sodium + sodium (laurilsulfoacétate de) + sorbitol à 70 pour cent cristallisable.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.